Literature DB >> 2139075

Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro.

C R Maliszewski1, T A Sato, T Vanden Bos, S Waugh, S K Dower, J Slack, M P Beckmann, K H Grabstein.   

Abstract

IL-1 and IL-4 are important mediators of B cell growth and differentiation. The cell-surface receptors for these cytokines have recently been cloned and recombinant soluble receptors have been produced that bind their respective ligand. The ability of soluble forms of the murine IL-1R (sIL-1R) and IL-4R (sIL-4R) to inhibit B cell functions in vitro was examined. Proliferation of B cells treated with anti-Ig plus IL-1 or IL-4 was inhibited by the appropriate soluble receptor. sIL-4R also inhibited IL-4-dependent B cell differentiation as measured by: induction of IgG1 and IgE secretion by LPS blasts, down-regulation of IgG3 secretion by LPS blasts, increased Ia expression, and increased Fc epsilon R (CD23) expression. The inhibitory effects of the soluble receptors were found to be highly specific in that sIL-4R had no effect on IL-1-induced B cell activity and sIL-1R had no effect on IL-4 activity, further demonstrating the existence of two independent pathways of B cell activation directed by IL-1 and IL-4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139075

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Deregulated inflammasome signaling in disease.

Authors:  Mohamed Lamkanfi; Lieselotte Vande Walle; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 2.  Immunotherapy for allergies and asthma: present and future.

Authors:  Shyam S Mohapatra; Momina Qazi; Gary Hellermann
Journal:  Curr Opin Pharmacol       Date:  2010-06-21       Impact factor: 5.547

Review 3.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

4.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.

Authors:  M K Spriggs; B H Koller; T Sato; P J Morrissey; W C Fanslow; O Smithies; R F Voice; M B Widmer; C R Maliszewski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 5.  Inflammasomes and autoimmunity.

Authors:  Patrick J Shaw; Michael F McDermott; Thirumala-Devi Kanneganti
Journal:  Trends Mol Med       Date:  2010-12-14       Impact factor: 11.951

Review 6.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

7.  Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).

Authors:  B König; A Fischer; W König
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

8.  Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system.

Authors:  C S Hsieh; A B Heimberger; J S Gold; A O'Garra; K M Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

9.  Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis.

Authors:  A Gessner; K Schröppel; A Will; K H Enssle; L Lauffer; M Röllinghoff
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation.

Authors:  T W Flickinger; N J Maihle; H J Kung
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.